Search Results for keywords:"2021 final rule"

Found 2 results

Search Results: keywords:"2021 final rule"

💰 Only
Oldest Newest
  • 2021-00932 — Civil Monetary Penalty Inflation Adjustment
    💰
    Type:Rule
    Citation:86 FR 7797
    Reading Time:about 5 minutes

    The Merit Systems Protection Board (MSPB) issued a final rule to adjust civil monetary penalties (CMPs) for 2021. This adjustment follows the Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015, which mandates annual inflation-based updates to penalties. For 2021, the penalties for certain violations are increased to a maximum of $1,125, rounded from a calculated amount based on an inflation multiplier. The adjustments ensure penalties maintain their deterrent effect and will be applied starting February 2, 2021.

    Simple Explanation

    The government made a new rule to slightly increase the fines people have to pay when they break certain rules, so that the fines still feel like a "big deal" and stop others from breaking the rules too. This change is like using a price tag that keeps up with money getting "less big" over time because things cost more now!

  • 2021-03251 — New Animal Drug Applications; Beta-Aminopropionitrile Fumarate; n-Butyl Chloride; Cupric Glycinate Injection; Dichlorophene and Toluene; Orgotein for Injection; Tetracycline Tablets
    Type:Rule
    Citation:86 FR 10818
    Reading Time:about 4 minutes

    The Food and Drug Administration (FDA) has updated regulations to reflect the withdrawal of approval for seven new animal drug applications due to non-compliance with reporting requirements. This change means that certain firms are no longer recognized as sponsors for these drugs. The decision takes effect on February 23, 2021, and involves technical amendments to various parts of the Code of Federal Regulations to ensure accuracy. The rule does not impose any new burdens on businesses and is not subject to further review or certain regulatory requirements.

    Simple Explanation

    The FDA took away permission for some medicines made for animals because the companies didn’t follow all the rules about telling the FDA how the medicines were working. This means the medicines might not be available from those companies anymore.